Pros and Cons of Medication-Assisted Treatment for Opioid Use Disorder

Medication-assisted treatments (MAT), methadone, buprenorphine, and extended-release naltrexone, approved by the FDA, have strong empiric evidence for superior outcomes compared with medication-free behavioral approaches or short-term detoxification. This slideshow presents the pros and cons of MAT modalities. For more on this topic, see Responding to the Opioid Epidemic and Expanding Access to Quality Treatment, on which this slideshow is based.